Simone Schimmer Selected Research

Retroviridae Infections (Infection, Retrovirus)

10/2017	Fas Ligand-mediated cytotoxicity of CD4+ T cells during chronic retrovirus infection.
1/2013	Combining regulatory T cell depletion and inhibitory receptor blockade improves reactivation of exhausted virus-specific CD8+ T cells and efficiently reduces chronic retroviral loads.
9/2011	Improved vaccine protection against retrovirus infection after co-administration of adenoviral vectors encoding viral antigens and type I interferon subtypes.
4/2006	Effects of type I interferons on Friend retrovirus infection.
12/2004	Independent roles of perforin, granzymes, and Fas in the control of Friend retrovirus infection.
7/2004	Protection of mice against Friend retrovirus infection by vaccination with antigen-loaded, spleen-derived dendritic cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Simone Schimmer Research Topics

Disease

18	Infections 03/2019 - 11/2002
11	Virus Diseases (Viral Diseases) 03/2019 - 10/2003
6	Retroviridae Infections (Infection, Retrovirus) 10/2017 - 07/2004
4	Neoplasms (Cancer) 03/2019 - 04/2007
4	Leukemia 12/2004 - 11/2002
2	Communicable Diseases (Infectious Diseases) 01/2013 - 02/2011
2	Persistent Infection 04/2007 - 08/2005
1	Coinfection 12/2016
1	Disease Progression 10/2003

Drug/Important Bio-Agent (IBA)

8	Antiviral Agents (Antivirals)IBA 10/2018 - 11/2002
7	CytokinesIBA 01/2018 - 04/2008
4	Granzymes (Granzyme)IBA 02/2013 - 12/2004
4	VaccinesIBA 01/2012 - 07/2004
3	OligodeoxyribonucleotidesIBA 04/2007 - 11/2002
2	AntibodiesIBA 03/2019 - 10/2017
2	AntigensIBA 10/2018 - 07/2004
2	Fas Ligand Protein (Fas Ligand)IBA 10/2017 - 12/2004
2	Proteins (Proteins, Gene)FDA Link 01/2012 - 02/2010
2	Interferon Type IIBA 09/2011 - 04/2006
2	PerforinIBA 08/2005 - 12/2004
2	CPG-oligonucleotideIBA 10/2003 - 11/2002
1	Interleukin-10 (Interleukin 10)IBA 01/2018
1	Interleukin-15 (Interleukin 15)IBA 11/2017
1	Interleukin-18 (Interleukin 18)IBA 11/2017
1	Galactosylceramides (Galactocerebrosides)IBA 01/2017
1	Immunoglobulin G (IgG)IBA 12/2016
1	Interleukin-2 (IL2)IBA 02/2013
1	LigandsIBA 01/2013
1	Blocking AntibodiesIBA 01/2013
1	Viral AntigensIBA 09/2011
1	Neutralizing AntibodiesIBA 01/2011
1	Complement System Proteins (Complement)IBA 01/2011
1	Capsid Proteins (Capsid Protein)IBA 02/2010
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 02/2010
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 04/2008
1	Messenger RNA (mRNA)IBA 08/2005

Therapy/Procedure

5	Immunotherapy 11/2017 - 03/2004
3	Therapeutics 03/2019 - 10/2003